SUMMARY Hepatic intestinal and whole body plasma clearance and appearance of noradrenaline (NA) was quantified in patients with alcoholic cirrhosis (n= 12) and in controls (n=6). As NA may be released as well as removed in the same vascular bed, infusion of tritium labelled NA (3H-NA) was carried out during hepatic vein catheterisation in order to determine both flux rates. In alcoholic cirrhosis plasma concentrations of endogeneous NA and adrenaline (A) were significantly above control values (NA: median 2 4 v 1-7 nmol/l, p<0 (2; A: 0(38 v 0 19 nmol/l, p<001). Whole body clearance of 3H-NA equal in the two groups (1 6 v 1 7 I/min, ns), while as the overall appearance rate of NA was significantly higher in alcoholic cirrhosis (4.2 v 2 6 nmol/min, p<0.02) indicating an enhanced sympathoadrenal activity in this group. The hepatic intestinal clearances of A, NA, and 3H-NA were not significantly different in patients and controls, but the estimated hepatic intestinal spillover rate of NA was 0-24 nmol/min in patients as compared with 0(0 nmol/ min in controls (p<002). As a result of portosystemic shunting in cirrhosis the present estimation of NA spillover represents a minimum value. Our results indicate that the augmented circulating catecholamines in cirrhosis do not result from diminished removal but are contributed to from increased sympathetic nervous activity in the sympathetic nervous activity).
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Noradrenaline (NA) is the neurotransmitter released from axon terminals of sympathetic postganglionic neurones which normally control cardiovascular responses during for example, postural changes and exercise.' Adrenaline (A), a hormone originating from the adrenal medulla, together with NA controls several functions, including metabolism and the secretion of other hormones. The concentrations of endogenous NA and A in plasma may be accurately measured by enzymatic isotope derivative techniques.2 This is important as NA leaks from the synaptic nerve terminals into the plasma where its concentration reflects the neurotransmitter activity, provided there is normal NA-clearance from hepatic intestinal area (enhanced mesenteric plasma.4 Because the same vascular bed may release as well as remove NA, quantification of NA-kinetics demands a method such as the application of labelled NA,`7 which is able to distinguish both flux rates.
Recent studies have shown an increased concentration of circulating NA in supine patients with decompensated cirrhosis.>"' The kidneys have been identified as a source of increased NA release in cirrhosis, but enhanced sympathetic nervous activity in other regions may also be important.'"' The gastrointestinal tract and the liver are richly supplied with sympathetic nerve fibres, and it is conceivable that the splanchnic system, besides removing NA, also releases this amine. Therefore, the objective of the study has been to quantify and compare the hepatic intestinal and the whole body uptake and release of NA in patients with cirrhosis and in control subjects. For this purpose we used constant intra-venous infusion of tritium labelled noradrenaline (3H-NA) during hepatic vein catheterisation.
Methods

PATI ENTS
The study comprised 12 Median values, ranges in parentheses; significantly different from controls: *p<002; tp<0 01.
Results
The biochemical and haemodynamic findings are summarised in Table 1 . Endogenous arterial plasma NA and A concentrations in patients with alcoholic cirrhosis were significantly above those of the controls (Table 2) . Arterial NA concentrations were positively correlated with wedged hepatic venous pressure (r = 0-51, p<005)
but not with any other haemodynamic variable. CIWB was equal in the two groups, and consequently the overall appearance rate of noradrenaline was significantly higher in the patient group ( Table 2) .
The estimated splanchnic (hepatic intestinal) release rate of noradrenaline (Js.reiease) was median 0-24 nmol/min in the cirrhotic patients as compared with 0*0 nmol/min in controls (p<002, Fig. 1 with EICG (r = 0-66, p<0O005; r = 0-58, p<0-01; r = 0-40, p<01, respectively, Fig. 2) . ClS,A, CIS,NA, and Cls,3H-NA were not significantly different in patients and controls (Fig. 3) . CIS NA, was significantly lower than CIsA and Cls,3H-NA (p<0 02, and p<0-01, respectively) in patients but not in controls. In patients splanchnic (hepatic intestinal) catecholThe present study shows that the removal of catecholamines from plasma is normal in patients with alcoholic cirrhosis, as determined from 3H-NA whole body and hepatic intestinal clearances. The raised circulating noradrenaline and adrenaline in some cirrhotic patients, therefore, reflect an increased appearance of catecholamines, indicating enhanced sympathoadrenal activity in this condition.
Enhanced sympathetic nervous activity in cirrhosis has been identified in the kidney"-'" and possibly in parts of the peripheral circulation.'7 The hepatic intestinal area, however, has not hitherto been evaluated with respect to sympathetic nervous activity by methods which allow estimation of unidirectional transport of catecholamines between the blood stream and the splanchnic organs.
The hepatic intestinal clearance of endogenous NA was significantly smaller than that of 3H-NA (p<0-01) and A (p<0-02) in patients but not in controls. This discordance between tracer and endogenous substance found in patients indicates that besides removal there is also a significant spillover of NA from the splanchnic system into the systemic circulation, as clearly shown in the present study (Fig. 1) . Hepatic intestinal NA release was absent in the controls. As all splanchnic blood passes through liver veins in normal subjects the estimated value is likely to be correct in that group. Patients with cirrhosis, however, have portosystemic shunts, and the estimated release of NA only covers the amount passing through the liver veins. An unknown quantity flows through the portosystemic collaterals. Therefore, in cirrhosis the present estimation of Js,release represents a minimum value. If it is assumed that the average blood flow through portosystemic collaterals amounts to 0-8 /min,'8 and the content of NA in plasma from these collaterals is similar to that of the hepatic vein, net release may be underestimated by: (0-8/1.43) * 0-24 nmol/min = 0*13 nmol/min. If the concentration of NA in collaterals is higher or the collaterals preferably drain -for example, spleen, reflecting local phenomena, the extent of this underestimation cannot be determined.
In the controls, hepatic intestinal extraction ratios of endogenous and tracer NA (ES,NA and ES,3H-NA)
were not significantly different from that of indocyanine green (EIcG), but the extraction ratio of A (ES,A) was approximately 25% higher (Table 3 ). In 
